Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06789198
Title Fusion Transcript-based Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Oncogenic Driver Fusion DNAJB1-PRKACA (FusionVAC22_02)
Acronym FusionVAC22_02
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Hospital Tuebingen
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
University Hospital Tuebingen Tübingen 72076 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field